4YX.F RED LIGHT HOLLAND CORP.

Healthcare Pharmaceuticals Frankfurt Exchange
0.0130 EUR
Close of Nov 11, 2026
0.0005 0.0300
Market cap
EUR 7.74M
P/E
-
P/B
0.34x
ROE
-39.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is 4YX.F undervalued?

Graham number

The Graham number of RED LIGHT HOLLAND CORP. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RED LIGHT HOLLAND CORP. fundamental analysis

No fundamental analysis for RED LIGHT HOLLAND CORP. yet.

RED LIGHT HOLLAND CORP. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RED LIGHT HOLLAND CORP.

Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. Its products also include PEX010, a natural psilocybin drug candidate for depression, PTSD, …

Full company profile